SciELO - Scientific Electronic Library Online

 
vol.160 issue2Contribution of memory T cells to the generation of long-lasting immunity against COVID-19Multimorbidity in people living with HIV and cancer in Mexico author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Gaceta médica de México

On-line version ISSN 2696-1288Print version ISSN 0016-3813

Abstract

CARPIO-ORANTES, Luis Del et al. Clinical-epidemiological characterization of patients with long COVID in Mexico. Gac. Méd. Méx [online]. 2024, vol.160, n.2, pp.144-151.  Epub Oct 25, 2024. ISSN 2696-1288.  https://doi.org/10.24875/gmm.23000385.

Background:

Long COVID is defined as the persistence of COVID-19 symptoms four weeks after having undergone acute infection, according to the most recent CDC definition. It is estimated that there are 65 million people affected by this entity, although other figures speak of 200 million.

Objective:

To characterize the population affected by long COVID in Mexico.

Material and methods:

Patients older than 18 years who agreed to answer an online survey and who met the criteria for long COVID were included.

Results:

Data from 203 subjects were included, with 138 (68.0%) being found to be females, and average age to be 41.8 years; 29.6% had severe disease, and 70.4%, mild to moderate disease; 89.7% had received prior COVID-19 vaccination: 6.9% had received one dose; 31.5%, two doses; and 51.2%, three or more doses. The main risk factors were diabetes, overweight or obesity, and hypertension. The most commonly reported symptom was fatigue, followed by other neuropsychiatric manifestations.

Conclusion:

It is important for the population affected by long COVID to be characterized in order to generate diagnostic and treatment protocols.

Keywords : Long COVID; Dysautonomia; Fatigue.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )